Circulating Preprandial Ghrelin to Obestatin Ratio Is Increased in Human Obesity
Authors:
Open Access
- 1 May 2007
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (5) , 1875-1880
Abstract
Context: Obestatin, a sibling of ghrelin derived from preproghrelin, opposes ghrelin’s effects on food intake. Plasma obestatin profiles in relation to ghrelin have not been fully investigated in human obesity. Objective: We hypothesize that obesity might present with imbalance of circulating ghrelin and obestatin levels. Participants and Setting: Sixteen obese (eight men, aged 58.8 ± 4.9 yr; eight women, aged 59.9 ± 9.6 yr) and 14 normal-weight individuals (seven men, aged 52.7 ± 5.9 yr; seven women, aged 56.1 ± 4.9 yr) were evaluated at the in-patient department of Changhai Hospital, Shanghai, China. Main Outcome Measures: Total plasma ghrelin and obestatin levels, 1 h before and 2 h after breakfast, were measured by RIA. Results: Both preprandial plasma ghrelin levels (P < 0.01) and obestatin levels (P < 0.01) were lower in the obese compared with normal-weight controls. However, unexpectedly, the ratio of preprandial ghrelin to obestatin was higher in obese compared with normal-weight controls (P < 0.01) even after adjustment for gender and age (P < 0.01). The ratio of postprandial ghrelin to obestatin was decreased both in obese (P < 0.05) and controls (P < 0.01) compared with their preprandial levels. There were no significant differences in the ratio of postprandial ghrelin to obestatin between obese and normal-weight controls. Body mass index was positively correlated with and was a significantly independent determinant of the preprandial ghrelin to obestatin ratio. Conclusion: Circulating preprandial ghrelin to obestatin ratio is elevated in human obesity. We suggest that high preprandial ghrelin to obestatin ratio may be involved in the etiology and pathophysiology of obesity.Keywords
This publication has 38 references indexed in Scilit:
- Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tractBritish Journal of Pharmacology, 2007
- Altered Gastrointestinal and Metabolic Function in the GPR39-Obestatin Receptor–Knockout MouseGastroenterology, 2006
- Ghrelin and the short- and long-term regulation of appetite and body weightPhysiology & Behavior, 2006
- Obese Subjects Respond to the Stimulatory Effect of the Ghrelin Agonist Growth Hormone‐Releasing Peptide‐2 on Food IntakeObesity, 2006
- Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food IntakeScience, 2005
- Ghrelin increases food intake in obese as well as lean subjectsInternational Journal of Obesity, 2005
- Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptorEuropean Journal of Pharmacology, 2004
- Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass SurgeryNew England Journal of Medicine, 2002
- Ghrelin Modulates the Downstream Molecules of Insulin Signaling in Hepatoma CellsJournal of Biological Chemistry, 2002